insulin glargine
- Product Nameinsulin glargine
- CAS160337-95-1
- CBNumberCB1547528
- MFC267H404N72O78S6
- MW6062.89026
- MDL NumberMFCD09260251
- MOL File160337-95-1.mol
- MSDS FileSDS
Chemical Properties
| storage temp. | -20°C, Inert atmosphere |
| solubility | Aqueous Acid (Very Slightly) |
| form | Liquid |
| color | White to Off-White |
| Sequence | A-chain: Gly-Ile-Val-Glu-Gln-Cys-Cys-Thr-Ser-Ile-Cys-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-Tyr-Cys-Gly; B-chain: Phe-Val-Asn-Gln-His-Leu-Cys-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Thr-Arg-Arg (Disulfide bridge: CysA6-CysA11, CysA7-CysB7, CysA20-CysB19) |
| InChIKey | COCFEDIXXNGUNL-RFKWWTKHSA-N |
| CAS DataBase Reference | 160337-95-1 |
| NCI Dictionary of Cancer Terms | insulin glargine; insulin glargine recombinant; Lantus |
| FDA UNII | 2ZM8CX04RZ |
| ATC code | A10AE04 |
| Comptox DTXSID | DTXSID0043927 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
Safety
| Symbol(GHS) |
|
| Signal word | Warning |
| Hazard statements | H373 |
| Precautionary statements | P260-P314-P501 |
| WGK Germany | nwg |
| HS Code | 2937120000 |
| Storage Class | 11 - Combustible Solids |